Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J3358 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Drugs, Administered by Injection |
| Common Place of Service | 11Office |
| Hospital Outpatient Group (APC) | APC 9487 - Ustekinumab, iv inject,1 mg |
| Surgery Center Payment (ASC) | K2 - Drug paid separately with a covered surgery, at the OPPS rate |
| Common Revenue Codes | 06360250 |
| Medicare Fee Schedule | $10.25 per 1 mg (October 2026 ASP)View Medicare rates for J3358 |
| Medicaid Fee Schedule | $11.85 median of the 8 states in the free previewView Medicaid rates for J3358 |
| Medicare Payment Limit | |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 57894005427 - Stelara (ustekinumab) 130 mg/26mL, solution • 57894044401 - Ustekinumab Inj 13026ml, Ustekinumab |
National average reimbursement for HCPCS J3358 by major payers:

$14.45
BCBS / Anthem

$13.41
UnitedHealthcare

$14.69
Aetna

$13.81
Cigna
Choose a payer to see a sample of rates for HCPCS J3358.
Northside Hospital, Inc., Northside Hospital
Northside Hospital Inc
Hyun Ah Yoon
Montefiore Medical Center
Deaconess Hospital, Inc.
Anesthesiology Group Associates, P.C.
Genghis Sanchez Garcia
Beth Israel Deaconess Medical Center Inc
Ram Parekh
New York City Health And Hospitals Corporation
Choose your state and specialty to build a report from payer-published rates.
Looking for other data?
Rate Benchmarking
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonPayer Contract Negotiation
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J3358 vs. Other Drugs, Administered by Injection Codes
The table lists codes related to J3358. Select one to see its fee schedule.
| Code | Description |
|---|---|
| 57894005427-NDC | Stelara (ustekinumab) 130 mg/26mL, solution |
| 57894044401-NDC | Ustekinumab Inj 13026ml, Ustekinumab |
| J3357-HCPCS | Ustekinumab, for subcutaneous injection, 1 mg |
| J3358-HCPCS | Ustekinumab, for intravenous injection, 1 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J3358. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J3358 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
Bring your top codes (like HCPCS J3358) and we'll show you how you compare in 15 minutes or less.
Medicare's hospital outpatient payment system (OPPS) assigns HCPCS J3358 to APC 9487 (Ustekinumab, iv inject,1 mg). An APC groups outpatient services that Medicare pays at the same base rate.
CMS lists HCPCS J3358 with ASC payment indicator K2: Drug paid separately with a covered surgery, at the OPPS rate.
Hospital price transparency files list HCPCS J3358 under these revenue codes: 0636 and 0250. A revenue code names the hospital department or charge category for the line; it does not change what the service is.